Sqi Diagnostics Inc (SQIDF) 0.2717 $SQIDF
SQI Diagnostics Announces Stock Option Grant
CNW Group - Fri Sep 18, 8:00AM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"

(TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that effective September 16, 2015, they have granted 340,000 stock options of which 200,000 has been granted to certain officers and directors. Independent directors did not receive options in this grant.
SQD.VN: 0.370 (unch)
SQI Diagnostics Reports Third Quarter Financial Results
CNW Group - Tue Aug 18, 3:32PM CDT
Revenue Growth Continues
SQD.VN: 0.370 (unch)
SQI Diagnostics to Announce Third Quarter 2015 Results
CNW Group - Mon Aug 10, 3:37PM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"

(TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the three and nine months ended June 30, 2015, after market close on Tuesday, August 18, 2015. President and CEO, Andrew Morris, along with Company management, will host a conference call on Wednesday August 19, 2015 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.370 (unch)
SQI Diagnostics Reports Second Quarter Financial Results
PR Newswire - Thu May 21, 4:00PM CDT
First Platform Delivery to Global Pharma Customer
SQD.VN: 0.370 (unch)
SQI Diagnostics to Announce Second Quarter 2015 Results
CNW Group - Thu May 14, 3:30PM CDT
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"

(TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the three and six months ended March 31, 2015, after market close on Thursday, May 21, 2015. President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday May 22, 2015 at 10:00 a.m. ET to review financial results and discuss business developments for the period.
SQD.VN: 0.370 (unch)
SQI Diagnostics to Extend Warrant Expiry
PR Newswire - Fri Apr 17, 8:00AM CDT
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI"

, today announced that it has received approval from the TSX Venture Exchange to extend the expiry of 5,126,044 outstanding common share purchase warrants ("the Warrants"

of the Company, which were issued in connection with the Company's May 2013 private placement financing.
SQD.VN: 0.370 (unch)
SQI Delivers Sqidlite System to Global Pharmaceutical Customer
CNW Group - Wed Apr 15, 8:00AM CDT
SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics ("SQI"

, today announced the delivery and installation of a sqidliteTM system under the terms of an agreement with a top tier global pharmaceutical customer. As previously disclosed, two custom immunogenicity assays have been successfully developed for this customer.
SQD.VN: 0.370 (unch)
Bristol-Myers Squibb to Highlight SQI's Technology at WRIB Conference
PR Newswire - Thu Apr 09, 8:00AM CDT
SQI's Strength in Immunogenicity Testing Featured In Multiple Presentations
O: 47.77 (+0.12), BMY: 61.44 (+0.93), SQD.VN: 0.370 (unch)
SQI Announces Election of Directors
CNW Group - Wed Apr 08, 1:32PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company"

(TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced the voting results for its nominees for director at its reconvened annual and special meeting of shareholders held today.
SQD.VN: 0.370 (unch)
SQI Diagnostics Inc. Announces Adjournment of Meeting
PR Newswire - Thu Mar 26, 12:10PM CDT
SQI Diagnostics Inc. ("SQI" or the "Company"

(TSX-V: SQD; OTCQX: SQIDF) announced that after dealing with certain matters, including the appointment of auditors, its annual and special meeting of shareholders held on March 26, 2015 (the "Meeting"

was adjourned, as previously disclosed on March 25, 2015, until April 8, 2015 at 11:00 a.m. (Toronto time). The date of the reconvened Meeting has been changed from that previous disclosed. The Meeting will reconvene at the offices of the Company's counsel, Gowling Lafleur Henderson LLP, located at 100 King Street West, Suite 1600, Toronto, Ontario.
SQD.VN: 0.370 (unch)